The present and future disease burden of hepatitis C virus infections with today's treatment paradigm - volume 3.

Clicks: 477
ID: 55097
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #3 of 14 articles by views in journal of viral hepatitis

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The total number, morbidity and mortality attributed to viraemic hepatitis C virus (HCV) infections change over time making it difficult to compare reported estimates from different years. Models were developed for 15 countries to quantify and characterize the viraemic population and forecast the changes in the infected population and the corresponding disease burden from 2014 to 2030. With the exception of Iceland, Iran, Latvia and Pakistan, the total number of viraemic HCV infections is expected to decline from 2014 to 2030, but the associated morbidity and mortality are expected to increase in all countries except for Japan and South Korea. In the latter two countries, mortality due to an ageing population will drive down prevalence, morbidity and mortality. On the other hand, both countries have already experienced a rapid increase in HCV-related mortality and morbidity. HCV-related morbidity and mortality are projected to increase between 2014 and 2030 in all other countries as result of an ageing HCV-infected population. Thus, although the total number of HCV countries is expected to decline in most countries studied, the associated disease burden is expected to increase. The current treatment paradigm is inadequate if large reductions in HCV-related morbidity and mortality are to be achieved.
Reference Key
sibley2015thejournal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sibley, A;Han, K H;Abourached, A;Lesmana, L A;Makara, M;Jafri, W;Salupere, R;Assiri, A M;Goldis, A;Abaalkhail, F;Abbas, Z;Abdou, A;Al Braiki, F;Al Hosani, F;Al Jaberi, K;Al Khatry, M;Al Mulla, M A;Al Quraishi, H;Al Rifai, A;Al Serkal, Y;Alam, A;Alavian, S M;Alashgar, H I;Alawadhi, S;Al-Dabal, L;Aldins, P;Alfaleh, F Z;Alghamdi, A S;Al-Hakeem, R;Aljumah, A A;Almessabi, A;Alqutub, A N;Alswat, K A;Altraif, I;Alzaabi, M;Andrea, N;Babatin, M A;Baqir, A;Barakat, M T;Bergmann, O M;Bizri, A R;Blach, S;Chaudhry, A;Choi, M S;Diab, T;Djauzi, S;El Hassan, E S;El Khoury, S;Estes, C;Fakhry, S;Farooqi, J I;Fridjonsdottir, H;Gani, R A;Ghafoor Khan, A;Gheorghe, L;Gottfredsson, M;Gregorcic, S;Gunter, J;Hajarizadeh, B;Hamid, S;Hasan, I;Hashim, A;Horvath, G;Hunyady, B;Husni, R;Jeruma, A;Jonasson, J G;Karlsdottir, B;Kim, D Y;Kim, Y S;Koutoubi, Z;Liakina, V;Lim, Y S;Löve, A;Maimets, M;Malekzadeh, R;Matičič, M;Memon, M S;Merat, S;Mokhbat, J E;Mourad, F H;Muljono, D H;Nawaz, A;Nugrahini, N;Olafsson, S;Priohutomo, S;Qureshi, H;Rassam, P;Razavi, H;Razavi-Shearer, D;Razavi-Shearer, K;Rozentale, B;Sadik, M;Saeed, K;Salamat, A;Sanai, F M;Sanityoso Sulaiman, A;Sayegh, R A;Sharara, A I;Siddiq, M;Siddiqui, A M;Sigmundsdottir, G;Sigurdardottir, B;Speiciene, D;Sulaiman, A;Sultan, M A;Taha, M;Tanaka, J;Tarifi, H;Tayyab, G;Tolmane, I;Ud Din, M;Umar, M;Valantinas, J;Videčnik-Zorman, J;Yaghi, C;Yunihastuti, E;Yusuf, M A;Zuberi, B F;Schmelzer, J D;
Journal journal of viral hepatitis
Year 2015
DOI
10.1111/jvh.12476
URL
Keywords
prevalence Epidemiology mortality treatment hepatitis c diagnosis incidence hepatitis c virus disease burden

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.